All In Biotech

Drug Trial Radar · NCT05508594

Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001

Analgesic Efficacy and Pharmacokinetic-pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 After Impacted Mandibular Third Molar Extraction - A Double-blind, Randomised, Placebo-controlled Study

Last checked: Nov 19, 2026Latest source record: Oct 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 220 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

220

Actual

Start

Sep 5, 2022

Primary completion

Oct 5, 2023

Study completion Oct 5, 2023

Sponsor

Lead sponsor
Cessatech A/SIndustry
Sponsor type
Industry
First posted
Aug 19, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A randomised, double-blind, parallel-group, study comparing the analgesic effect of intranasal CT001 to intranasal sufentanil, intranasal ketamine or placebo for treatment of acute pain in adults undergoing surgical removal of an impacted mandibular third molar, where bone removal is judged to be needed.

Conditions

  • Pain

Interventions

  • CT001Drug

    Intranasal

  • PlaceboDrug

    Intranasal

  • SufentanilDrug

    Intranasal

  • KetamineDrug

    Intranasal

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sum of pain intensity differences at 55 minTime frame: 0-55 min
  2. PK-PD relationship for analgesic efficacy IN sufentanil, IN ketamine and IN CT001Time frame: 0-180 min

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • DanTrials

    Copenhagen, NV, Denmark

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.